Swedish Orphan Biovitrum AB (publ)

BIOVF · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$307$794$1,096$1,437
Dep. & Amort.$796$889$938$932
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$57$0$0
Change in WC-$167-$190$1,024-$127
Other Non-Cash-$128-$102-$763-$445
Operating Cash Flow$195$1,448$2,295$1,797
Investing Activities
PP&E Inv.-$285-$20-$7-$13
Net Acquisitions$0$0$0$0
Inv. Purchases-$1$0-$37$0
Inv. Sales/Matur.$0$6$0$0
Other Inv. Act.$0-$410-$50-$88
Investing Cash Flow-$286-$424-$94-$101
Financing Activities
Debt Repay.$85-$1,330-$2,348-$1,344
Stock Issued$1$34$3$1
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$5$308$52$193
Financing Cash Flow$91-$988-$2,293-$1,150
Forex Effect-$1$25-$50-$1
Net Chg. in Cash-$1$61-$143$546
Supplemental Information
Beg. Cash$111$997$1,140$594
End Cash$110$1,058$997$1,140
Free Cash Flow$194$1,027$2,284$1,736